401 related articles for article (PubMed ID: 35166235)
21. Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer.
Kwong TNY; Wang X; Nakatsu G; Chow TC; Tipoe T; Dai RZW; Tsoi KKK; Wong MCS; Tse G; Chan MTV; Chan FKL; Ng SC; Wu JCY; Wu WKK; Yu J; Sung JJY; Wong SH
Gastroenterology; 2018 Aug; 155(2):383-390.e8. PubMed ID: 29729257
[TBL] [Abstract][Full Text] [Related]
22. Gut microbiota imbalance and colorectal cancer.
Gagnière J; Raisch J; Veziant J; Barnich N; Bonnet R; Buc E; Bringer MA; Pezet D; Bonnet M
World J Gastroenterol; 2016 Jan; 22(2):501-18. PubMed ID: 26811603
[TBL] [Abstract][Full Text] [Related]
23. The association between fecal microbiota and different types of colorectal polyp as precursors of colorectal cancer.
Rezasoltani S; Asadzadeh Aghdaei H; Dabiri H; Akhavan Sepahi A; Modarressi MH; Nazemalhosseini Mojarad E
Microb Pathog; 2018 Nov; 124():244-249. PubMed ID: 30142468
[TBL] [Abstract][Full Text] [Related]
24. Gut Microbiota, Inflammation, and Colorectal Cancer.
Brennan CA; Garrett WS
Annu Rev Microbiol; 2016 Sep; 70():395-411. PubMed ID: 27607555
[TBL] [Abstract][Full Text] [Related]
25. Altered intestinal microbiota associated with colorectal cancer.
Zhang H; Chang Y; Zheng Q; Zhang R; Hu C; Jia W
Front Med; 2019 Aug; 13(4):461-470. PubMed ID: 31250341
[TBL] [Abstract][Full Text] [Related]
26. Association of Polygenic Risk Score and Bacterial Toxins at Screening Colonoscopy with Colorectal Cancer Progression: A Multicenter Case-Control Study.
Piciocchi A; Germinario EAP; Garcia Etxebarria K; Rossi S; Sanchez-Mete L; Porowska B; Stigliano V; Trentino P; Oddi A; Accarpio F; Grazi GL; Bruno G; Bonucci M; Giambenedetti M; Spigaglia P; Barbanti F; Owczarek S; Luzzi I; Delibato E; Maroccia Z; Nisticò L; Fiorentini C; D'Amato M; De Angelis R; Fabbri A
Toxins (Basel); 2021 Aug; 13(8):. PubMed ID: 34437440
[TBL] [Abstract][Full Text] [Related]
27. [Gut microbiota: What impact on colorectal carcinogenesis and treatment?].
Bruneau A; Baylatry MT; Joly AC; Sokol H
Bull Cancer; 2018 Jan; 105(1):70-80. PubMed ID: 29217301
[TBL] [Abstract][Full Text] [Related]
28. Three specific gut bacteria in the occurrence and development of colorectal cancer: a concerted effort.
Gong D; Adomako-Bonsu AG; Wang M; Li J
PeerJ; 2023; 11():e15777. PubMed ID: 37554340
[TBL] [Abstract][Full Text] [Related]
29. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
[TBL] [Abstract][Full Text] [Related]
30. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
[TBL] [Abstract][Full Text] [Related]
31. Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study.
Zhang Y; Yu X; Yu E; Wang N; Cai Q; Shuai Q; Yan F; Jiang L; Wang H; Liu J; Chen Y; Li Z; Jiang Q
BMC Microbiol; 2018 Aug; 18(1):92. PubMed ID: 30157754
[TBL] [Abstract][Full Text] [Related]
32. 16S rRNA of Mucosal Colon Microbiome and CCL2 Circulating Levels Are Potential Biomarkers in Colorectal Cancer.
Nardelli C; Granata I; Nunziato M; Setaro M; Carbone F; Zulli C; Pilone V; Capoluongo ED; De Palma GD; Corcione F; Matarese G; Salvatore F; Sacchetti L
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639088
[TBL] [Abstract][Full Text] [Related]
33. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
[TBL] [Abstract][Full Text] [Related]
34. The gut microbiota can orchestrate the signaling pathways in colorectal cancer.
Bennedsen ALB; Furbo S; Bjarnsholt T; Raskov H; Gögenur I; Kvich L
APMIS; 2022 Mar; 130(3):121-139. PubMed ID: 35007370
[TBL] [Abstract][Full Text] [Related]
35. Biofilms and core pathogens shape the tumor microenvironment and immune phenotype in colorectal cancer.
Kvich L; Fritz BG; Zschach H; Terkelsen T; Raskov H; Høst-Rasmussen K; Jakobsen MR; Gheorghe AG; Gögenur I; Bjarnsholt T
Gut Microbes; 2024; 16(1):2350156. PubMed ID: 38726597
[TBL] [Abstract][Full Text] [Related]
36. Metagenomic analysis of the fecal microbiome in colorectal cancer patients compared to healthy controls as a function of age.
Kharofa J; Apewokin S; Alenghat T; Ollberding NJ
Cancer Med; 2023 Feb; 12(3):2945-2957. PubMed ID: 36056757
[TBL] [Abstract][Full Text] [Related]
37. The Role of the Gut Microbiota in Colorectal Cancer Causation.
Alhinai EA; Walton GE; Commane DM
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653078
[TBL] [Abstract][Full Text] [Related]
38. Tumour-associated and non-tumour-associated microbiota: Addendum.
Flemer B; Herlihy M; O'Riordain M; Shanahan F; O'Toole PW
Gut Microbes; 2018 Jul; 9(4):369-373. PubMed ID: 29420132
[TBL] [Abstract][Full Text] [Related]
39. Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers.
Hale VL; Jeraldo P; Chen J; Mundy M; Yao J; Priya S; Keeney G; Lyke K; Ridlon J; White BA; French AJ; Thibodeau SN; Diener C; Resendis-Antonio O; Gransee J; Dutta T; Petterson XM; Sung J; Blekhman R; Boardman L; Larson D; Nelson H; Chia N
Genome Med; 2018 Oct; 10(1):78. PubMed ID: 30376889
[TBL] [Abstract][Full Text] [Related]
40. The presence of bacteria varies between colorectal adenocarcinomas, precursor lesions and non-malignant tissue.
Bundgaard-Nielsen C; Baandrup UT; Nielsen LP; Sørensen S
BMC Cancer; 2019 Apr; 19(1):399. PubMed ID: 31035942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
